25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

NATCO PHARMA LTD.
Buy, Hold or Sell?

Let's analyze NATCO PHARMA LTD. together

I guess you are interested in NATCO PHARMA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of NATCO PHARMA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about NATCO PHARMA LTD.

I send you an email if I find something interesting about NATCO PHARMA LTD..

1. Quick Overview

1.1. Quick analysis of NATCO PHARMA LTD. (30 sec.)










1.2. What can you expect buying and holding a share of NATCO PHARMA LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.45
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR326.79
Expected worth in 1 year
INR-369.11
How sure are you?
83.3%

+ What do you gain per year?

Total Gains per Share
INR-657.75
Return On Investment
-44.7%

For what price can you sell your share?

Current Price per Share
INR1,470.20
Expected price per share
INR1,321 - INR1,591
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of NATCO PHARMA LTD. (5 min.)




Live pricePrice per Share (EOD)
INR1,470.20
Intrinsic Value Per Share
INR382.74 - INR880.60
Total Value Per Share
INR709.53 - INR1,207.39

2.2. Growth of NATCO PHARMA LTD. (5 min.)




Is NATCO PHARMA LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$690.6m$1b-$387.5m-56.1%

How much money is NATCO PHARMA LTD. making?

Current yearPrevious yearGrowGrow %
Making money$163.8m$84.4m$79.4m48.5%
Net Profit Margin34.7%26.4%--

How much money comes from the company's main activities?

2.3. Financial Health of NATCO PHARMA LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of NATCO PHARMA LTD.?

Welcome investor! NATCO PHARMA LTD.'s management wants to use your money to grow the business. In return you get a share of NATCO PHARMA LTD..

First you should know what it really means to hold a share of NATCO PHARMA LTD.. And how you can make/lose money.

Speculation

The Price per Share of NATCO PHARMA LTD. is INR1,470. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of NATCO PHARMA LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in NATCO PHARMA LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR326.79. Based on the TTM, the Book Value Change Per Share is INR-173.97 per quarter. Based on the YOY, the Book Value Change Per Share is INR267.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR9.54 per quarter.
Based on historical numbers we can estimate the returns while holding a share of NATCO PHARMA LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.910.1%0.910.1%0.460.0%0.410.0%0.410.0%
Usd Book Value Change Per Share-2.05-0.1%-2.05-0.1%3.150.2%0.320.0%0.640.0%
Usd Dividend Per Share0.110.0%0.110.0%0.060.0%0.080.0%0.070.0%
Usd Total Gains Per Share-1.94-0.1%-1.94-0.1%3.220.2%0.400.0%0.720.0%
Usd Price Per Share11.23-11.23-6.65-8.50-8.21-
Price to Earnings Ratio12.28-12.28-14.38-32.42-29.72-
Price-to-Total Gains Ratio-5.79--5.79-2.07-22.90-19.57-
Price to Book Ratio2.91-2.91-1.13-2.67-2.73-
Price-to-Total Gains Ratio-5.79--5.79-2.07-22.90-19.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share17.34836
Number of shares57
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.110.08
Usd Book Value Change Per Share-2.050.32
Usd Total Gains Per Share-1.940.40
Gains per Quarter (57 shares)-110.6022.67
Gains per Year (57 shares)-442.4090.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
126-468-452187381
251-936-89435146172
377-1404-133653219263
4103-1872-177871292354
5128-2340-222088365445
6154-2808-2662106438536
7180-3276-3104123511627
8205-3744-3546141584718
9231-4213-3988159657809
10257-4681-4430176730900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of NATCO PHARMA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---173.973-173.9730%267.165-165%27.152-741%54.465-419%
Book Value Per Share--326.788326.7880%500.761-35%299.032+9%281.031+16%
Current Ratio--4.1364.1360%4.392-6%3.977+4%3.851+7%
Debt To Asset Ratio--0.1520.1520%-0.615+503%0.003+4277%0.034+344%
Debt To Equity Ratio--0.1800.1800%-0.714+497%0.008+2193%0.045+297%
Dividend Per Share--9.5369.5360%5.502+73%6.557+45%6.302+51%
Enterprise Value--159891165000.000159891165000.0000%137649280319.750+16%131040345623.850+22%125256435919.275+28%
Eps--77.51177.5110%39.201+98%35.103+121%35.130+121%
Ev To Ebitda Ratio--infinfnan%13.233+inf%infnan%infnan%
Ev To Sales Ratio--3.9983.9980%5.085-21%5.771-31%5.588-28%
Free Cash Flow Per Share--47.61947.6190%35.266+35%15.557+206%14.853+221%
Free Cash Flow To Equity Per Share--47.61947.6190%15.372+210%7.167+564%7.397+544%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--880.605--------
Intrinsic Value_10Y_min--382.743--------
Intrinsic Value_1Y_max--37.971--------
Intrinsic Value_1Y_min--21.523--------
Intrinsic Value_3Y_max--152.400--------
Intrinsic Value_3Y_min--79.627--------
Intrinsic Value_5Y_max--313.021--------
Intrinsic Value_5Y_min--153.683--------
Market Cap263327522000.000+35%170423165000.000170423165000.0000%102849280319.750+66%130820945623.850+30%126427102585.942+35%
Net Profit Margin--0.3470.3470%0.264+31%0.241+44%0.253+37%
Operating Margin----0%0.299-100%0.183-100%0.210-100%
Operating Ratio--0.7880.7880%0.947-17%1.018-23%0.994-21%
Pb Ratio4.499+35%2.9122.9120%1.126+159%2.673+9%2.726+7%
Pe Ratio18.968+35%12.27612.2760%14.378-15%32.417-62%29.716-59%
Price Per Share1470.200+35%951.500951.5000%563.650+69%720.750+32%695.892+37%
Price To Free Cash Flow Ratio30.874+35%19.98219.9820%15.983+25%92.581-78%85.557-77%
Price To Total Gains Ratio-8.941-55%-5.786-5.7860%2.067-380%22.899-125%19.569-130%
Quick Ratio--3.0513.0510%2.761+10%2.394+27%2.369+29%
Return On Assets--0.2010.2010%0.126+59%0.111+82%0.117+72%
Return On Equity--0.2370.2370%0.147+62%0.131+82%0.140+70%
Total Gains Per Share---164.437-164.4370%272.668-160%33.709-588%60.767-371%
Usd Book Value--690665800.000690665800.0000%1078213200.000-36%641027920.000+8%602846266.667+15%
Usd Book Value Change Per Share---2.053-2.0530%3.153-165%0.320-741%0.643-419%
Usd Book Value Per Share--3.8563.8560%5.909-35%3.529+9%3.316+16%
Usd Dividend Per Share--0.1130.1130%0.065+73%0.077+45%0.074+51%
Usd Enterprise Value--1886715747.0001886715747.0000%1624261507.773+16%1546276078.361+22%1478025943.847+28%
Usd Eps--0.9150.9150%0.463+98%0.414+121%0.415+121%
Usd Free Cash Flow--100642200.000100642200.0000%75933000.000+33%33113160.000+204%31667266.667+218%
Usd Free Cash Flow Per Share--0.5620.5620%0.416+35%0.184+206%0.175+221%
Usd Free Cash Flow To Equity Per Share--0.5620.5620%0.181+210%0.085+564%0.087+544%
Usd Market Cap3107264759.600+35%2010993347.0002010993347.0000%1213621507.773+66%1543687158.361+30%1491839810.514+35%
Usd Price Per Share17.348+35%11.22811.2280%6.651+69%8.505+32%8.212+37%
Usd Profit--163819400.000163819400.0000%84405400.000+94%74937080.000+119%75120766.667+118%
Usd Revenue--471858400.000471858400.0000%319437800.000+48%287658040.000+64%280263766.667+68%
Usd Total Gains Per Share---1.940-1.9400%3.217-160%0.398-588%0.717-371%
 EOD+3 -5MRQTTM+0 -0YOY+23 -165Y+27 -1110Y+27 -11

3.3 Fundamental Score

Let's check the fundamental score of NATCO PHARMA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.968
Price to Book Ratio (EOD)Between0-14.499
Net Profit Margin (MRQ)Greater than00.347
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.051
Current Ratio (MRQ)Greater than14.136
Debt to Asset Ratio (MRQ)Less than10.152
Debt to Equity Ratio (MRQ)Less than10.180
Return on Equity (MRQ)Greater than0.150.237
Return on Assets (MRQ)Greater than0.050.201
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of NATCO PHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.517
Ma 20Greater thanMa 501,402.808
Ma 50Greater thanMa 1001,394.780
Ma 100Greater thanMa 2001,429.581
OpenGreater thanClose1,466.400
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About NATCO PHARMA LTD.

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-12-08 14:27:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit NATCO PHARMA LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare NATCO PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 34.7% means that ₹0.35 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NATCO PHARMA LTD.:

  • The MRQ is 34.7%. The company is making a huge profit. +2
  • The TTM is 34.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ34.7%TTM34.7%0.0%
TTM34.7%YOY26.4%+8.3%
TTM34.7%5Y24.1%+10.6%
5Y24.1%10Y25.3%-1.2%
4.3.1.2. Return on Assets

Shows how efficient NATCO PHARMA LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare NATCO PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 20.1% Return on Assets means that NATCO PHARMA LTD. generated ₹0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NATCO PHARMA LTD.:

  • The MRQ is 20.1%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 20.1%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ20.1%TTM20.1%0.0%
TTM20.1%YOY12.6%+7.5%
TTM20.1%5Y11.1%+9.0%
5Y11.1%10Y11.7%-0.7%
4.3.1.3. Return on Equity

Shows how efficient NATCO PHARMA LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare NATCO PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 23.7% Return on Equity means NATCO PHARMA LTD. generated ₹0.24 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NATCO PHARMA LTD.:

  • The MRQ is 23.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 23.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ23.7%TTM23.7%0.0%
TTM23.7%YOY14.7%+9.0%
TTM23.7%5Y13.1%+10.7%
5Y13.1%10Y14.0%-0.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of NATCO PHARMA LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient NATCO PHARMA LTD. is operating .

  • Measures how much profit NATCO PHARMA LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare NATCO PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NATCO PHARMA LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY29.9%-29.9%
TTM-5Y18.3%-18.3%
5Y18.3%10Y21.0%-2.7%
4.3.2.2. Operating Ratio

Measures how efficient NATCO PHARMA LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are ₹0.79 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of NATCO PHARMA LTD.:

  • The MRQ is 0.788. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.788. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.788TTM0.7880.000
TTM0.788YOY0.947-0.159
TTM0.7885Y1.018-0.230
5Y1.01810Y0.994+0.024
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of NATCO PHARMA LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if NATCO PHARMA LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.14 means the company has ₹4.14 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of NATCO PHARMA LTD.:

  • The MRQ is 4.136. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.136. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.136TTM4.1360.000
TTM4.136YOY4.392-0.256
TTM4.1365Y3.977+0.159
5Y3.97710Y3.851+0.126
4.4.3.2. Quick Ratio

Measures if NATCO PHARMA LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare NATCO PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.05 means the company can pay off ₹3.05 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NATCO PHARMA LTD.:

  • The MRQ is 3.051. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.051. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.051TTM3.0510.000
TTM3.051YOY2.761+0.289
TTM3.0515Y2.394+0.657
5Y2.39410Y2.369+0.025
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of NATCO PHARMA LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of NATCO PHARMA LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare NATCO PHARMA LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.15 means that NATCO PHARMA LTD. assets are financed with 15.2% credit (debt) and the remaining percentage (100% - 15.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of NATCO PHARMA LTD.:

  • The MRQ is 0.152. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.152. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.152TTM0.1520.000
TTM0.152YOY-0.615+0.768
TTM0.1525Y0.003+0.149
5Y0.00310Y0.034-0.031
4.5.4.2. Debt to Equity Ratio

Measures if NATCO PHARMA LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare NATCO PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 18.0% means that company has ₹0.18 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NATCO PHARMA LTD.:

  • The MRQ is 0.180. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.180. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.180TTM0.1800.000
TTM0.180YOY-0.714+0.894
TTM0.1805Y0.008+0.172
5Y0.00810Y0.045-0.037
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings NATCO PHARMA LTD. generates.

  • Above 15 is considered overpriced but always compare NATCO PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 12.28 means the investor is paying ₹12.28 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NATCO PHARMA LTD.:

  • The EOD is 18.968. Based on the earnings, the company is fair priced.
  • The MRQ is 12.276. Based on the earnings, the company is underpriced. +1
  • The TTM is 12.276. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD18.968MRQ12.276+6.692
MRQ12.276TTM12.2760.000
TTM12.276YOY14.378-2.103
TTM12.2765Y32.417-20.141
5Y32.41710Y29.716+2.701
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of NATCO PHARMA LTD.:

  • The EOD is 30.874. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 19.982. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 19.982. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD30.874MRQ19.982+10.893
MRQ19.982TTM19.9820.000
TTM19.982YOY15.983+3.999
TTM19.9825Y92.581-72.599
5Y92.58110Y85.557+7.024
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of NATCO PHARMA LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.91 means the investor is paying ₹2.91 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of NATCO PHARMA LTD.:

  • The EOD is 4.499. Based on the equity, the company is fair priced.
  • The MRQ is 2.912. Based on the equity, the company is underpriced. +1
  • The TTM is 2.912. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.499MRQ2.912+1.587
MRQ2.912TTM2.9120.000
TTM2.912YOY1.126+1.786
TTM2.9125Y2.673+0.239
5Y2.67310Y2.726-0.053
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets69,063,000
Total Liabilities10,532,000
Total Stockholder Equity58,531,000
 As reported
Total Liabilities 10,532,000
Total Stockholder Equity+ 58,531,000
Total Assets = 69,063,000

Assets

Total Assets69,063,000
Total Current Assets40,235,000
Long-term Assets28,828,000
Total Current Assets
Cash And Cash Equivalents 704,000
Short-term Investments 17,788,000
Net Receivables 11,889,000
Inventory 7,005,000
Other Current Assets 2,759,000
Total Current Assets  (as reported)40,235,000
Total Current Assets  (calculated)40,145,000
+/- 90,000
Long-term Assets
Property Plant Equipment 24,350,000
Goodwill 560,000
Intangible Assets 1,371,000
Long-term Assets Other 694,000
Long-term Assets  (as reported)28,828,000
Long-term Assets  (calculated)26,975,000
+/- 1,853,000

Liabilities & Shareholders' Equity

Total Current Liabilities9,728,000
Long-term Liabilities804,000
Total Stockholder Equity58,531,000
Total Current Liabilities
Short Long Term Debt 3,632,000
Accounts payable 2,355,000
Other Current Liabilities 1,341,000
Total Current Liabilities  (as reported)9,728,000
Total Current Liabilities  (calculated)7,328,000
+/- 2,400,000
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt80,000
Long-term Liabilities  (as reported)804,000
Long-term Liabilities  (calculated)80,000
+/- 724,000
Total Stockholder Equity
Total Stockholder Equity (as reported)58,531,000
Total Stockholder Equity (calculated)0
+/- 58,531,000
Other
Capital Stock358,000
Common Stock Shares Outstanding 179,110
Net Debt 2,928,000
Net Invested Capital 62,163,000
Net Working Capital 30,507,000
Property Plant and Equipment Gross 24,350,000



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
43,031,000
45,878,000
47,919,000
51,091,000
56,574,000
69,063,000
69,063,00056,574,00051,091,00047,919,00045,878,00043,031,00000
   > Total Current Assets 
10,873,000
21,307,000
23,472,000
23,256,000
23,448,000
24,867,000
30,003,000
40,235,000
40,235,00030,003,00024,867,00023,448,00023,256,00023,472,00021,307,00010,873,000
       Cash And Cash Equivalents 
0
0
283,000
198,000
258,000
1,111,000
1,319,000
704,000
704,0001,319,0001,111,000258,000198,000283,00000
       Short-term Investments 
0
0
10,293,000
8,827,000
7,844,000
6,488,000
10,302,000
17,788,000
17,788,00010,302,0006,488,0007,844,0008,827,00010,293,00000
       Net Receivables 
4,971,000
6,827,000
6,068,000
5,513,000
4,129,000
6,206,000
8,561,000
11,889,000
11,889,0008,561,0006,206,0004,129,0005,513,0006,068,0006,827,0004,971,000
       Inventory 
3,695,000
4,577,000
5,908,000
6,987,000
9,104,000
8,620,000
8,089,000
7,005,000
7,005,0008,089,0008,620,0009,104,0006,987,0005,908,0004,577,0003,695,000
       Other Current Assets 
778,000
1,335,000
781,000
731,000
960,000
1,467,000
1,914,000
2,759,000
2,759,0001,914,0001,467,000960,000731,000781,0001,335,000778,000
   > Long-term Assets 
0
0
19,559,000
22,622,000
24,546,000
26,119,000
26,571,000
28,828,000
28,828,00026,571,00026,119,00024,546,00022,622,00019,559,00000
       Property Plant Equipment 
11,635,000
14,927,000
18,561,000
20,937,000
22,372,000
23,084,000
23,034,000
24,350,000
24,350,00023,034,00023,084,00022,372,00020,937,00018,561,00014,927,00011,635,000
       Goodwill 
0
0
0
0
0
507,000
552,000
560,000
560,000552,000507,00000000
       Intangible Assets 
0
0
87,000
88,000
94,000
822,000
1,326,000
1,371,000
1,371,0001,326,000822,00094,00088,00087,00000
       Long-term Assets Other 
0
0
17,000
-1,000
285,000
469,000
271,000
694,000
694,000271,000469,000285,000-1,00017,00000
> Total Liabilities 
0
0
8,121,000
8,031,000
6,685,000
8,455,000
-34,800,000
10,532,000
10,532,000-34,800,0008,455,0006,685,0008,031,0008,121,00000
   > Total Current Liabilities 
6,265,000
5,920,000
7,287,000
6,853,000
5,256,000
7,104,000
6,831,000
9,728,000
9,728,0006,831,0007,104,0005,256,0006,853,0007,287,0005,920,0006,265,000
       Short Long Term Debt 
0
0
3,863,000
3,277,000
2,821,000
4,205,000
1,650,000
3,632,000
3,632,0001,650,0004,205,0002,821,0003,277,0003,863,00000
       Accounts payable 
2,627,000
2,691,000
2,170,000
2,554,000
1,462,000
1,618,000
2,638,000
2,355,000
2,355,0002,638,0001,618,0001,462,0002,554,0002,170,0002,691,0002,627,000
       Other Current Liabilities 
985,000
902,000
799,000
568,000
484,000
677,000
1,752,000
1,341,000
1,341,0001,752,000677,000484,000568,000799,000902,000985,000
   > Long-term Liabilities 
0
0
834,000
1,178,000
1,429,000
1,351,000
-41,631,000
804,000
804,000-41,631,0001,351,0001,429,0001,178,000834,00000
       Capital Lease Obligations Min Short Term Debt
0
0
0
17,000
18,000
115,000
17,000
80,000
80,00017,000115,00018,00017,000000
> Total Stockholder Equity
0
0
34,890,000
37,735,000
41,216,000
42,636,000
48,738,000
58,531,000
58,531,00048,738,00042,636,00041,216,00037,735,00034,890,00000
   Common Stock
349,000
369,000
365,000
364,000
365,000
365,000
365,000
0
0365,000365,000365,000364,000365,000369,000349,000
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
277,000
310,000
511,000
656,000
659,000
932,000
790,000
0
0790,000932,000659,000656,000511,000310,000277,000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue39,988,000
Cost of Revenue-7,166,000
Gross Profit32,822,00032,822,000
 
Operating Income (+$)
Gross Profit32,822,000
Operating Expense-24,342,000
Operating Income15,646,0008,480,000
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense24,342,0000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-192,000
Other Finance Cost-0
Net Interest Income-192,000
 
Pretax Income (+$)
Operating Income15,646,000
Net Interest Income-192,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)16,735,00015,646,000
EBIT - interestExpense = -192,000
13,883,000
14,075,000
Interest Expense192,000
Earnings Before Interest and Taxes (EBIT)016,927,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax16,735,000
Tax Provision-2,852,000
Net Income From Continuing Ops13,883,00013,883,000
Net Income13,883,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0192,000
 

Technical Analysis of NATCO PHARMA LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of NATCO PHARMA LTD.. The general trend of NATCO PHARMA LTD. is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine NATCO PHARMA LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of NATCO PHARMA LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,591.

The bearish price targets are: 1,428 > 1,335 > 1,321.

Tweet this
NATCO PHARMA LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of NATCO PHARMA LTD.. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

NATCO PHARMA LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of NATCO PHARMA LTD.. The current macd is 22.81.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the NATCO PHARMA LTD. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for NATCO PHARMA LTD.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the NATCO PHARMA LTD. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
NATCO PHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) ChartNATCO PHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of NATCO PHARMA LTD.. The current adx is 17.91.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy NATCO PHARMA LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
NATCO PHARMA LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of NATCO PHARMA LTD.. The current sar is 1,384.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
NATCO PHARMA LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of NATCO PHARMA LTD.. The current rsi is 62.52. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
NATCO PHARMA LTD. Daily Relative Strength Index (RSI) ChartNATCO PHARMA LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of NATCO PHARMA LTD.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the NATCO PHARMA LTD. price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
NATCO PHARMA LTD. Daily Stochastic Oscillator ChartNATCO PHARMA LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of NATCO PHARMA LTD.. The current cci is 91.52.

NATCO PHARMA LTD. Daily Commodity Channel Index (CCI) ChartNATCO PHARMA LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of NATCO PHARMA LTD.. The current cmo is 32.99.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
NATCO PHARMA LTD. Daily Chande Momentum Oscillator (CMO) ChartNATCO PHARMA LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of NATCO PHARMA LTD.. The current willr is -20.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that NATCO PHARMA LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
NATCO PHARMA LTD. Daily Williams %R ChartNATCO PHARMA LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of NATCO PHARMA LTD..

NATCO PHARMA LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of NATCO PHARMA LTD.. The current atr is 38.78.

NATCO PHARMA LTD. Daily Average True Range (ATR) ChartNATCO PHARMA LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of NATCO PHARMA LTD.. The current obv is 5,343,462.

NATCO PHARMA LTD. Daily On-Balance Volume (OBV) ChartNATCO PHARMA LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of NATCO PHARMA LTD.. The current mfi is 78.16.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
NATCO PHARMA LTD. Daily Money Flow Index (MFI) ChartNATCO PHARMA LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for NATCO PHARMA LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

NATCO PHARMA LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of NATCO PHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.517
Ma 20Greater thanMa 501,402.808
Ma 50Greater thanMa 1001,394.780
Ma 100Greater thanMa 2001,429.581
OpenGreater thanClose1,466.400
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of NATCO PHARMA LTD. with someone you think should read this too:
  • Are you bullish or bearish on NATCO PHARMA LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about NATCO PHARMA LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about NATCO PHARMA LTD.

I send you an email if I find something interesting about NATCO PHARMA LTD..


Comments

How you think about this?

Leave a comment

Stay informed about NATCO PHARMA LTD..

Receive notifications about NATCO PHARMA LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.